日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Identifying a cancer therapeutic target: Cell-SELEX identifies a membrane protein for aptamer-mediated growth suppression

确定癌症治疗靶点：Cell-SELEX 鉴定出一种膜蛋白，可用于适体介导的生长抑制

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2514681123
Cui, Wei; Xiao, Hang; Wen, Xiaohong; Li, Chen; Bao, Suxia; Zeng, Jiahao; Li, Yangbing; Qiao, Yan; Wang, Kemin; Wang, Honghui; Huang, Jin; Guo, Qiuping
SELE
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Hyperopic reserve as a predictor of myopia incidence in schoolchildren aged 6-12 years: a 24-month prospective cohort study

远视储备作为6-12岁学龄儿童近视发生率的预测指标：一项为期24个月的前瞻性队列研究

期刊:Frontiers in Public Health
影响因子:3.4
doi:10.3389/fpubh.2025.1660168
Dong, Wei; Fu, Kunlin; Zhang, Ye; Li, Yangbing; Liu, Chengfei; Wang, Zihao; Li, Yanying; Song, Boyang; Du, Zhaojiang
发表日期：2025
文献求助 收藏

FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma

FDA批准摘要：达拉非尼联合曲美替尼治疗BRAFV600E突变阳性低级别胶质瘤

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1503
Barbato, Michael I; Nashed, Jeannette; Bradford, Diana; Ren, Yi; Khasar, Sachia; Miller, Claudia P; Zolnik, Banu S; Zhao, Hong; Li, Yangbing; Bi, Youwei; Shord, Stacy S; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Scepura, Barbara; Al-Matari, Raniya A; Pazdur, Richard; Kluetz, Paul G; Donoghue, Martha; Singh, Harpreet; Drezner, Nicole
胶质瘤
BRAF
发表日期：2024
文献求助 收藏

FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

FDA批准摘要：瑞波替尼用于治疗局部晚期或转移性ROS1阳性非小细胞肺癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0949
Barbato, Michael I; Bradford, Diana; Ren, Yi; Aungst, Stephanie L; Miller, Claudia P; Pan, Lili; Zirkelbach, Jeanne F; Li, Yangbing; Bi, Youwei; Fan, Jianghong; Grimstein, Manuela; Dorff, Sarah E; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Scepura, Barbara; Schotland, Peter; Udoka, Opeyemi; Ojofeitimi, Idara; Leighton, John K; Rahman, Nam A; Pazdur, Richard; Singh, Harpreet; Kluetz, Paul G; Drezner, Nicole
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia

MD-265 的发现：一种强效的 MDM2 降解剂，可实现肿瘤完全消退并提高白血病小鼠的长期生存率

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.4c01818
Aguilar, Angelo; Yang, Jiuling; Li, Yangbing; McEachern, Donna; Huang, Liyue; Razzouk, Stevenchoukry; Wang, Shaomeng
白血病
MDM2
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement

FDA批准摘要：Pemigatinib用于治疗既往接受过治疗、无法切除的局部晚期或转移性胆管癌，伴有FGFR2融合或其他重排

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2036
Patel, Timil H; Marcus, Leigh; Horiba, M Naomi; Donoghue, Martha; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Schuck, Robert N; Li, Yangbing; Zhang, Xinyuan; Fourie Zirkelbach, Jeanne; Charlab, Rosane; Liu, Jiang; Yang, Yuching; Lemery, Steven J; Pazdur, Richard; Theoret, Marc R; Fashoyin-Aje, Lola A
肿瘤
胆管癌
FGFR2
肿瘤免疫
发表日期：2023
文献求助 收藏

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

FDA批准摘要：Amivantamab用于治疗携带EGFR 20号外显子插入突变的非小细胞肺癌患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3713
Chon, Katie; Larkins, Erin; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Aungst, Stephanie; Wearne, Emily; Subramaniam, Sriram; Li, Yangbing; Liu, Jiang; Sun, Jielin; Charlab, Rosane; Zhao, Hong; Saritas-Yildirim, Banu; Bikkavilli, Rama Kamesh; Ghosh, Soma; Philip, Reena; Beaver, Julia A; Singh, Harpreet
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏

FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors

FDA批准摘要：Selpercatinib用于治疗晚期RET融合阳性实体瘤

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0459
Duke, Elizabeth S; Bradford, Diana; Marcovitz, Michelle; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Nguyen, Emily; Price, Lauren S L; Fourie Zirkelbach, Jeanne; Li, Yangbing; Bi, Youwei; Kraft, Jeffrey; Dorff, Sarah E; Scepura, Barbara; Stephenson, Maritsa; Ojofeitimi, Idara; Nair, Abhilasha; Han, Yu; Tezak, Zivana; Lemery, Steven J; Pazdur, Richard; Larkins, Erin; Singh, Harpreet
RET
发表日期：2023
文献求助 收藏

FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer

FDA批准摘要：图卡替尼联合曲妥珠单抗用于治疗晚期不可切除或转移性、化疗难治性、HER2阳性、RAS野生型结直肠癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-1041
Casak, Sandra J; Horiba, M Naomi; Yuan, Mengdie; Cheng, Joyce; Lemery, Steven J; Shen, Yuan Li; Fu, Wentao; Moore, Jason N; Li, Yangbing; Bi, Youwei; Auth, Doris; Fesenko, Nataliya; Kluetz, Paul G; Pazdur, Richard; Fashoyin-Aje, Lola A
肿瘤
肠癌
肿瘤免疫
HER2
RAS
发表日期：2023
文献求助 收藏

Understanding the Relationships between Landscape Eco-Security and Multifunctionality in Cropland: Implications for Supporting Cropland Management Decisions

了解农田景观生态安全与多功能性之间的关系：对支持农田管理决策的启示

期刊:International Journal of Environmental Research and Public Health
影响因子:
doi:10.3390/ijerph20031938
Tang, Fang; Li, Yangbing; Liu, Xiuming; Huang, Juan; Zhang, Yiyi; Xu, Qian
发表日期：2023
文献求助 收藏